| Bioactivity | PARP1-IN-30 is a specific and potent PARP1 inhibitor with cytotoxicity. PARP1-IN-30 allows precise inhibition of PARP1 in tumor cells with breast cancer 1 protein (BRCA1) or BRCA2 deficiencies. PARP1-IN-30 is promising for research of cancers[1]. |
| CAS | 908803-38-3 |
| Formula | C14H12ClNO4S |
| Molar Mass | 325.77 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nemetova U, et al. Synthesis and In Silico Evaluation of Piperazine-Substituted 2,3-Dichloro-5,8-dihydroxy-1,4-naphthoquinone Derivatives as Potential PARP-1 Inhibitors. ACS Omega. 2024 Sep 10;9(38):39733-39742. |
PARP1-IN-30
CAS: 908803-38-3 F: C14H12ClNO4S W: 325.77
PARP1-IN-30 is a specific and potent PARP1 inhibitor with cytotoxicity. PARP1-IN-30 allows precise inhibition of PARP1 i
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.